Filing Details
- Accession Number:
- 0001179929-22-000143
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-23 20:30:22
- Reporting Period:
- 2022-09-22
- Accepted Time:
- 2022-09-23 20:30:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1179929 | Molina Healthcare Inc. | MOH | Hospital & Medical Service Plans (6324) | 134204626 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1320929 | M Joseph Zubretsky | 2180 Harvard Street Suite 400 Sacramento CA 95815 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-22 | 30,000 | $67.33 | 285,157 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-22 | 18,814 | $330.46 | 266,343 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-09-22 | 8,686 | $331.48 | 257,657 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-09-22 | 2,500 | $332.22 | 255,157 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-09-22 | 30,000 | $0.00 | 30,000 | $67.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 257,124 | 2027-10-08 | No | 4 | M | Direct |
Footnotes
- As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan.
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $330.00 to $330.99. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $331.00 to $331.99. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $332.01 to $332.86. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- 30,372 shares vest on March 1, 2023; 15,412 shares vest on March 1, 2024; 6,412 shares vest on March 1, 2025. The remainder of the shares are vested.
- The options are fully vested.
Billionaire Hedge Funds
